What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
His main research concerns Positron emission tomography, Nuclear medicine, Radiology, Internal medicine and Giant cell arteritis.
His research in Positron emission tomography is mostly concerned with Fluorodeoxyglucose.
His Nuclear medicine study incorporates themes from Prospective cohort study, Retrospective cohort study, Tomography, Survival analysis and Metabolic bone disease.
His Radiology research is multidisciplinary, incorporating perspectives in Rectum, Predictive value of tests and Vegetation.
His studies in Internal medicine integrate themes in fields like Gastroenterology, Surgery and Cardiology.
Luc Mortelmans interconnects Reperfusion therapy, Percutaneous coronary intervention, ST elevation, Myocardial infarction complications and Ventricular remodeling in the investigation of issues within Transplantation.
His most cited work include:
- Passage of inhaled particles into the blood circulation in humans. (1218 citations)
- Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. (1202 citations)
- Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. (429 citations)
What are the main themes of his work throughout his whole career to date?
Luc Mortelmans mainly focuses on Nuclear medicine, Internal medicine, Positron emission tomography, Radiology and Cardiology.
His Nuclear medicine research is multidisciplinary, relying on both Tomography, Perfusion and Lymphoma.
His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology, Endocrinology and Oncology.
His Positron emission tomography course of study focuses on Pathology and Apoptosis.
His study in the field of Fluorodeoxyglucose also crosses realms of In patient.
His study in Cardiology concentrates on Myocardial infarction, Ejection fraction and Coronary artery disease.
He most often published in these fields:
- Nuclear medicine (25.50%)
- Internal medicine (24.26%)
- Positron emission tomography (22.52%)
What were the highlights of his more recent work (between 2006-2020)?
- Positron emission tomography (22.52%)
- Nuclear medicine (25.50%)
- Radiology (19.55%)
In recent papers he was focusing on the following fields of study:
Luc Mortelmans mainly investigates Positron emission tomography, Nuclear medicine, Radiology, Pathology and Medical emergency.
He combines subjects such as Prostate, Molecular imaging, Magnetic resonance imaging, Prostate cancer and Pharmacology with his study of Positron emission tomography.
His study in Nuclear medicine focuses on Pet imaging in particular.
Many of his research projects under Radiology are closely connected to In patient with In patient, tying the diverse disciplines of science together.
Luc Mortelmans interconnects Apoptosis and Bioluminescence imaging in the investigation of issues within Pathology.
The various areas that Luc Mortelmans examines in his Medical emergency study include Nursing, Emergency department and Emergency medicine.
Between 2006 and 2020, his most popular works were:
- Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism (401 citations)
- [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor (239 citations)
- Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain. (239 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
The scientist’s investigation covers issues in Positron emission tomography, Nuclear medicine, Pathology, Biodistribution and Internal medicine.
His Positron emission tomography study combines topics from a wide range of disciplines, such as Cannabinoid, Metastasis, Pharmacology and Infarction.
His research in Nuclear medicine intersects with topics in H&E stain, Myocardial infarction, Perfusion scanning and Lymphoma.
His work on Necrosis as part of his general Pathology study is frequently connected to Pamoic acid, Rat Rhabdomyosarcoma, 18f fmiso and Fetus, thereby bridging the divide between different branches of science.
His Biodistribution research includes elements of Amyloid beta, Thymidine and Amyloidosis.
His research is interdisciplinary, bridging the disciplines of Endocrinology and Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
